Mohamed Baradia, DO
Pain Medicine · Houston, TXNPI 1528454378
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,293 of the $1,788 with a category attached, or 72.3%. Boston Scientific accounts for 60.3% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2023 at $937 and has fallen 94.9% since, to $48 in 2025. That places this record below the midpoint for pain medicine clinicians in TX, where the typical reported total is $3,132.
Across 20 payments — averaging $89.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$1K
- Stimwave Technologies Incorporated$352
- Abbott$266
- AbbVie$29
- Stryker$28
- GSK$20
- plus $16 from 1 others
What the payments were for
- Travel & lodging$1,29372%
- Food & beverage$49628%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 6 | $1,078 |
| Stimwave Technologies Incorporated | 2 | $352 |
| Abbott | 8 | $266 |
| AbbVie | 1 | $29 |
| Stryker | 1 | $28 |
| GSK | 1 | $20 |
| Novartis | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- StimQ Receiver Stimulator Kit Channel A US w Receiver$322
- StimQ Freedom-4A Receiver Kit Channel A US w/ Receiver$322
- StimQ Freedom 8A Receiver Kit Channel A US w Receiver$322
- Freedom 4A Receiver Kit Channel A US w Receiver$322
- Freedom 8A Receiver Kit Channel A US w Receiver$322
- Proclaim Family of SCS IPGs$160
- WaveWriter Alpha Prime 16$122
- GENERAL PAIN MANAGEMENT$120
How this compares
$1,788 in reported general payments places this provider in the 35th percentile of 583 pain medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 67 | $2,309 |
| Gabapentin | 80 | $1,710 |
| Methocarbamol | 24 | $852 |
| Pregabalin | 24 | $512 |
| Diclofenac Sodium | 17 | $380 |
| Cyclobenzaprine Hcl | 20 | $329 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 21 | $224 |
| Duloxetine Hcl | 15 | $223 |
| Oxycodone Hcl | 11 | $216 |
| Tizanidine Hcl | 12 | $144 |
| Tramadol Hcl | 28 | $139 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Houston
- Grant ChenHouston$175K
- Gunjan PatelHouston$166K
- Jaideep MehtaHouston$134K
- David LeimanHouston$131K
- Daniel PakHouston$117K
- Mitchell EngleHouston$72K
- Mayur KanjiaHouston$46K
- Baominh VinhHouston$44K
- Matthew ChungHouston$26K
- Thuan DaoHouston$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.